{"id":2015,"date":"2024-11-18T18:04:05","date_gmt":"2024-11-18T18:04:05","guid":{"rendered":"https:\/\/medical-article.com\/?p=2015"},"modified":"2024-11-18T18:04:05","modified_gmt":"2024-11-18T18:04:05","slug":"syndax-pharmaceuticals-leukemia-drug-wins-a-first-in-class-fda-approval","status":"publish","type":"post","link":"https:\/\/medical-article.com\/?p=2015","title":{"rendered":"Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval"},"content":{"rendered":"<p><a href=\"https:\/\/medcitynews.com\/2024\/11\/leukemia-syndax-pharmaceuticals-fda-approval-revuforj-menin-inhibitor-sndx\/\"><\/a><\/p>\n<p>Approval of Syndax\u2019s Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson &amp; Johnson subsidiary Janssen. <\/p>\n<p>The post <a href=\"https:\/\/medcitynews.com\/2024\/11\/leukemia-syndax-pharmaceuticals-fda-approval-revuforj-menin-inhibitor-sndx\/\">Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval<\/a> appeared first on <a href=\"https:\/\/medcitynews.com\/\">MedCity News<\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Approval of Syndax\u2019s Revuforj for acute leukemia makes the twice-daily pill the first in a new class of drugs that block a cancer-driving protein called menin. Other companies developing menin inhibitors include Kura Oncology, Biomea Fusion, and Johnson &amp; Johnson subsidiary Janssen. The post Syndax Pharmaceuticals Leukemia Drug Wins a First-in-Class FDA Approval appeared first&#8230;<\/p>\n","protected":false},"author":0,"featured_media":2016,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-2015","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine"],"_links":{"self":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/2015"}],"collection":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2015"}],"version-history":[{"count":0,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/posts\/2015\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=\/wp\/v2\/media\/2016"}],"wp:attachment":[{"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2015"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2015"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medical-article.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2015"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}